Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3b, Randomized, Double-Blind, Placebo-Control, Multicenter, Evaluation of the Safety and Efficacy of N1539 Administered Preoperatively in Open Unilateral Total Knee Arthroplasty

NCT03434275 is registered in ClinicalTrials.gov with Baudax Bio as lead sponsor.

NCT NCT03434275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03434275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3b, Randomized, Double-Blind, Placebo-Control, Multicenter, Evaluation of the Safety and Efficacy of N1539 Administered Preoperatively in Open Unilateral Total Knee Arthroplasty
Lead sponsor
Baudax Bio
Phase
Phase 3
Overall status
Completed
Start date
February 19, 2018
Completion date
May 21, 2019
Enrollment
194 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative